logo

For the Inventor, By the Inventor

Boston, MA, United States of America

Ginkgo Bioworks, Inc.


USPTO Granted Patents = 36

% Expired Patents = 5.6



Trademarks = 15

Forward Citations = 146

Loading Chart...
Loading Chart...

80 inventors (with patents filed for the assignee):

goldMedal Arthur J Shaw, Iv (7 out of 14 patents)

silverMedal Reshma P Shetty (7 out of 9 patents)

bronzeMedal Daniel Mccoy (6 out of 6 patents)

4.  Garrett E Berry (6 out of 6 patents)

5.  Curt R Fischer (5 out of 7 patents)

6.  Elena E Brevnova (4 out of 9 patents)

7.  Austin J Che (4 out of 4 patents)

8.  Jason R Kelly (4 out of 4 patents)

9.  Brian Roger Bowman (3 out of 9 patents)

10.  Daniel C Gray (3 out of 3 patents)

11.  Vasiliki Tsakraklides (3 out of 6 patents)

12.  Gregory Lawrence Verdine (3 out of 85 patents)

13.  Jeffrey Ian Boucher (2 out of 2 patents)

14.  Emily H Greenhagen (2 out of 3 patents)

15.  Nicholas Flores (2 out of 2 patents)


Core Competencies:
Biosynthesis
Engineered Microorganisms
Plant Health
Virus Vectors
Lipid Production
Chemoautotrophic Cells
Metabolic Engineering
Antibody-Evading
Recombinant Bacteria
Fermentation
Promoters
Organic Compounds

36 patents:

1. 12674810 - Scalable, mobile, and reconfigurable modules for processing biological and chemical materials (2026-07-07),
2. 12474548 - Optical lens assembly and a head-mounted electronic device (2025-11-18),
3. 12239137 - Compositions and methods for controlling plant pests and improving plant health (2025-03-04),
4. 12234464 - Biosynthesis of mogrosides (2025-02-25),
5. 12116384 - Virus vectors for targeting ophthalmic tissues (2024-10-15),
6. 12091435 - Antibody-evading virus vectors (2024-09-17),
7. 12077799 - Chimeric terpene synthases (2024-09-03),
8. 12060390 - Antibody-evading virus vectors (2024-08-13),
9. 11981914 - Recombinant adeno-associated virus vectors (2024-05-14),
10. 11976096 - Antibody-evading virus vectors (2024-05-07),
11. 11905523 - Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-C (2024-02-20),
12. 11859189 - Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof (2024-01-02),
13. 11702665 - -based endospore display platform, products and methods (2023-07-18),
14. 11697829 - Chemoautotrophic cells comprising an engineered carbon fixation pathway (2023-07-11),
15. 11674162 - Selective advantage in fermentation (2023-06-13),
Company Overview
Ginkgo Bioworks, based in Boston, specializes in the field of synthetic biology, focusing on designing custom microbes for a variety of applications. The company leverages advanced genetic engineering techniques to develop organisms that can produce valuable substances, ranging from pharmaceuticals to agricultural products. By integrating biology with cutting-edge technology, Ginkgo aims to revolutionize industries through innovative solutions that enhance sustainability and efficiency in production processes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Ginkgo Bioworks, Inc. USPTO Patent Assignee Logo
36 Patents

#64 in Boston, MA

#561 in Massachusetts

#9,502 in US

#18,716 in the World

Boston, MA (US)
Boston, MA, United States of America

Ginkgo Bioworks, Inc.

Forward Citations = 146

80 inventors:

goldMedal Arthur J Shaw, Iv (7 out of 14 patents)

silverMedal Reshma P Shetty (7 out of 9 patents)

bronzeMedal Daniel Mccoy (6 out of 6 patents)

4.  Garrett E Berry (6 out of 6 patents)

5.  Curt R Fischer (5 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ginkgo Bioworks, Inc.. Retrieved from https://idiyas.com/company/ginkgo-bioworks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…